Melanoma News and Research

Latest Melanoma News and Research

Sniffing out skin cancer by smell

According to researchers in the U.S. the smell skin gives off could indicate the presence of skin cancers. They say cancers such as basal cell carcinomas can be identified by the odour on the skin.

25 Aug 2008

Skin odors used to detect basal cell carcinoma

According to new research from the Monell Center, odors from skin can be used to identify basal cell carcinoma, the most common form of skin cancer. The findings, presented at the 236th meeting of the American Chemical Society, may open doors to development of new methods to detect basal cell carcinoma and other forms of skin cancer.

20 Aug 2008

Fish melanoma gene linked to pigment pattern that attracts mates

Though skin cancer is deadly to male fish, it also has one perk: The black melanoma splotches arise from attractive natural markings that lure female mates. A new study published in the Proceedings of the National Academy of Sciences this week shows that the melanoma gene can be conserved in swordtail fish because of its beneficial role in sexual selection.

18 Aug 2008

Concerns about possible cancer cluster prompts investigation of Gold Coast private hospital

A possible cancer cluster at a private hospital at Benowa on the Gold Coast is causing some concern.

4 Aug 2008

Many cancer patients found to be using complementary and alternative methods

A new study from researchers at the American Cancer Society finds many cancer patients use complementary and alternative methods, most often prayer, relaxation, supplements, meditation, and massage. Meanwhile, the use of other methods, such as biofeedback, homeopathy, and acupressure, are relatively uncommon.

4 Aug 2008

No doubt: sun causes melanomas

A leading University of Sydney researcher writes in the prestigious British Medical Journal today that claims that the sun is not the key cause of melanomas are false.

22 Jul 2008

Is staying out of the sun causing us more harm than good?

We are continuously bombarded with messages about the dangers of too much sun and the increased risk of melanoma (the less common and deadliest form of skin cancer), but are these dangers real, or is staying out of the sun causing us more harm than good?

22 Jul 2008

Researchers find better way to distinguish melanoma from some benign moles

University of Rochester Medical Center researchers found a new protein produced excessively in malignant melanoma, a discovery that is particularly relevant as skin cancer rates climb dramatically among young women.

17 Jul 2008

Nanomaterials key to new strategies for blocking metastasis

A new treatment strategy using targeted nanoparticles to block metastasis with anti-cancer drugs leads to good results using significantly lower doses of toxic chemotherapy, with less collateral damage to surrounding tissue, according to a collaborative team of researchers at the Center of Nanotechnology for Treatment, Understanding, and Monitoring of Cancer at the University of California, San Diego. In designing this system, the investigators, led by David Cheresh, Ph.D., have identified what may become a generic method for using nanotechnology to target metastasis.

9 Jul 2008

Cancer cases up but survival more than doubles in breast and bowel cancer

The number of people surviving some of the most common types of cancer for at least five years has doubled since the National Health Service was founded 60 years ago.

3 Jul 2008

Discovery of gene mechanism could lead to new therapeutic strategies to fight metastatic disease

Virginia Commonwealth University and VCU Massey Cancer Center researchers have uncovered how a gene, melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24), induces a bystander effect that kills cancer cells not directly receiving mda-7/IL-24 without harming healthy ones, a discovery that could lead to new therapeutic strategies to fight metastatic disease.

1 Jul 2008

Children's Brain Tumor Foundation's tissue bank consortium may solve dire problem in pediatric cancer research

In a major effort to speed treatment and cures for pediatric brain tumors and cancer, the Children's Brain Tumor Foundation (CBTF) today launched the initial phase of a tissue bank consortium designed to jump-start meaningful analyses that could lead to treatment and cures for these types of cancer, where survival rates are unacceptably low and neurocognitive and other damage is posed by today's treatment options.

1 Jul 2008

Harbor House to assist transplant and critical care patients, families

A dream of local heart transplant patients and volunteers is coming true much earlier than expected thanks to a generous gift provided by a local nonprofit organization.

25 Jun 2008

Patient's own infection-fighting T cells put late-stage melanoma into long-term remission

Researchers describe the first successful use of a human patient's cloned infection-fighting T cells as the sole therapy to put an advanced solid-tumor cancer into long-term remission. A team led by Cassian Yee, M.D., an associate member of the Clinical Research Division at Fred Hutchinson Cancer Research Center, reports these findings in the June 19 issue of the New England Journal of Medicine.

19 Jun 2008

Scientists cure advanced skin cancer with body's own cells

Scientists in the U.S. are claiming they have cured advanced skin cancer by using the patient's own cells.

19 Jun 2008

Melanomas "run" in families - CDKN2A gene reveals why

When people know the results of genetic tests confirming they have inherited an increased risk of developing melanoma, they follow skin cancer screening recommendations more proactively-much like those who have already been diagnosed with the potentially deadly disease, according to results of a study completed at the University of Utah's Huntsman Cancer Institute. and published in the June issue of Cancer Epidemiology, Biomarkers & Prevention.

17 Jun 2008

Nanoparticles trigger built-in cell-death signal to overcome drug resistance

One of the most vexing problems in treating cancer is the propensity of tumors to develop resistance to a wide range of anticancer drugs. Over 70 percent of ovarian cancer patients, for example, have drug-resistant tumors at the time of their initial diagnosis, and virtually all patients who relapse have drug-resistant tumors.

15 Jun 2008

Industry supports international melanoma research

Provectus Pharmaceuticals and the Australia and New Zealand Melanoma Trials Group (ANZMTG) have joined forces to advance cutting edge melanoma research at the University of Sydney.

15 Jun 2008

Arthritis drugs used in children to be investigated because of cancer link

Authorities in the United States are investigating certain types of drugs used to treat arthritis and other conditions.

5 Jun 2008

Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with Methotrexate

A chronic, inflammatory disease of unknown origin, rheumatoid arthritis (RA) affects about 1 percent of adults worldwide. Marked by joint destruction, RA often leads to disability and diminished quality of life. It can also lead to an early death from cancer.

3 Jun 2008